Variables | |
---|---|
Participants, n | 3,005 |
Age, years ± SD | 23.9 ± 10.8 |
Women, n (%) | 1,700 (56) |
Age at diagnosis of Type 1 DM in years, n (%) | |
0–4.9 | 330 (11) |
5–9.9 | 721 (24) |
10–14.9 | 932 (31) |
15–19.9 | 492 (16.4) |
20–29.9 | 414 (13.5) |
≥ 30 | 126 (4.1) |
Mean age at diagnosis of Type 1 DM, years ± SD | 13 ± 7.9 |
Duration of Type 1 DM, years | 10.9 (7 months – 50 years) |
Ethnicity, n (%) | |
Caucasian | 1,720 (57.2) |
Non-Caucasian | 1,285 (42.8) |
Economic class, % | |
High | 7.7 |
Medium | 24.3 |
Low | 34.2 |
Very low | 66.1 |
Geographic Region, n (%) | |
Southeast | 1,180 (39.3) |
North-Northeast | 925 (30.8) |
South | 718 (23.9) |
Midwest | 182 (6.0) |
Monthly family income, number of minimum wages ± SD | 2.3 ± 1.4 |
Practice of physical activity, times per week ± SD | 3.6 ± 1.4 |
Microvascular complications, n (%) | 673 (29.6) |
Macrovascular complications, n (%) | 124 (5.5) |
Type 1 DM treatment, % | |
Intermediate-acting insulin | 16.3 |
Long-acting insulin | 1.3 |
Insulin pump | 1.5 |
Intermediate- or long- and short-acting insulin | 80.8 |
Amount of insulin usage, UI/Kg/day ± SD | 0.9 ± 0.4 |